NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Clinical trials for NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) explained in plain language.
Never miss a new study
Get alerted when new NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) trials appear
Sign up with your email to follow new studies for NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug KO-2806 enters first human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called KO-2806 in adults with advanced solid tumors that have not responded to standard treatments. The study aims to find safe doses and see if the drug can shrink tumors when used alone or with other cancer medicines. About 300 participan…
Matched conditions: NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
New drug cocktail aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called XL092, alone or with other immune-boosting drugs, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find safe doses and see if the combination can shrink tumors or slow their gro…
Matched conditions: NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated May 19, 2026 11:46 UTC